Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Revenue | $10.3B | $12.6B | $9.3B | $9.7B | $9.8B | |
Revenue Growth (YoY) | 22.68% | 21.48% | -25.6% | 4.07% | 1.05% | |
Cost of Revenues | $6.6B | $8.3B | $6B | $6.2B | $6.1B | |
Gross Profit | $3.7B | $4.2B | $3.3B | $3.5B | $3.7B | |
Gross Profit Margin | 36.03% | 33.49% | 35.86% | 36.04% | 37.43% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.7B | $3.5B | $2.1B | $2.2B | $2.1B | |
Other Inc / (Exp) | -$306M | -$88M | -$303M | -$99M | -$296M | |
Operating Expenses | $2.7B | $3.5B | $2.1B | $2.2B | $2.1B | |
Operating Income | $1.1B | $688M | $1.2B | $1.3B | $1.6B | |
Net Interest Expenses | $337M | $334M | $212M | $281M | $621M | |
EBT. Incl. Unusual Items | $413M | $266M | $719M | $941M | $663M | |
Earnings of Discontinued Ops. | -- | -- | $102M | -$17.3B | -$7.2B | |
Income Tax Expense | $100M | $96M | $403M | $325M | $157M | |
Net Income to Company | $303M | $164M | $424M | -$16.7B | -$6.6B | |
Minority Interest in Earnings | -$5M | -$6M | -$7M | -$12M | -$7M | |
Net Income to Common Excl Extra Items | $298M | $158M | $417M | -$16.7B | -$6.7B | |
Basic EPS (Cont. Ops) | $0.67 | $0.26 | $0.68 | -$27.68 | -$11.26 | |
Diluted EPS (Cont. Ops) | $0.66 | $0.25 | $0.67 | -$27.68 | -$11.26 | |
Weighted Average Basic Share | $445M | $619M | $616M | $604M | $591M | |
Weighted Average Diluted Share | $451M | $627M | $621M | $604M | $591M | |
EBITDA | $3.2B | $4.3B | $4.9B | $5.1B | $4.1B | |
EBIT | $802M | $605M | $933M | $1.2B | $1.4B | |
Revenue (Reported) | $10.3B | $12.6B | $9.3B | $9.7B | $9.8B | |
Operating Income (Reported) | $1.1B | $688M | $1.2B | $1.3B | $1.6B | |
Operating Income (Adjusted) | $802M | $605M | $933M | $1.2B | $1.4B |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $3.2B | $3.5B | $2.4B | $2.5B | $2.6B | |
Revenue Growth (YoY) | 13.29% | 9.7% | -31.14% | 3.19% | 3.13% | |
Cost of Revenues | $2.1B | $2.2B | $1.5B | $1.5B | $1.6B | |
Gross Profit | $1.1B | $1.3B | $881M | $961M | $977M | |
Gross Profit Margin | 34.19% | 37.9% | 36.48% | 38.56% | 38.02% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $862M | $989M | $480M | $484M | $521M | |
Other Inc / (Exp) | -$4M | -$92M | $1M | $4M | -$40M | |
Operating Expenses | $862M | $989M | $480M | $484M | $485M | |
Operating Income | $231M | $340M | $401M | $477M | $492M | |
Net Interest Expenses | $84M | $46M | $78M | $162M | $64M | |
EBT. Incl. Unusual Items | $143M | $202M | $324M | $319M | $388M | |
Earnings of Discontinued Ops. | -- | -- | $32M | -$708M | -$22M | |
Income Tax Expense | $121M | $41M | $102M | $70M | $108M | |
Net Income to Company | $21M | $161M | $254M | $262M | $224M | |
Minority Interest in Earnings | -$2M | -$3M | -$5M | -$2M | -$1M | |
Net Income to Common Excl Extra Items | $20M | $158M | $249M | -$461M | $224M | |
Basic EPS (Cont. Ops) | $0.03 | $0.26 | $0.41 | -$0.78 | $0.41 | |
Diluted EPS (Cont. Ops) | $0.03 | $0.26 | $0.41 | -$0.78 | $0.41 | |
Weighted Average Basic Share | $620M | $613M | $605M | $592M | $545M | |
Weighted Average Diluted Share | $627M | $619M | $607M | $592M | $548M | |
EBITDA | $1.2B | $1.3B | $1.3B | $916M | $884M | |
EBIT | $227M | $248M | $402M | $481M | $452M | |
Revenue (Reported) | $3.2B | $3.5B | $2.4B | $2.5B | $2.6B | |
Operating Income (Reported) | $231M | $340M | $401M | $477M | $492M | |
Operating Income (Adjusted) | $227M | $248M | $402M | $481M | $452M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $12.6B | $13.5B | $8.8B | $9.8B | $10B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $8.2B | $8.5B | $5.6B | $6.2B | $6.2B | |
Gross Profit | $4.4B | $5B | $3.2B | $3.6B | $3.8B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $3.8B | $3.9B | $1.7B | $2.1B | $2.2B | |
Other Inc / (Exp) | -$180M | -$380M | -$38M | -$176M | -$439M | |
Operating Expenses | $3.8B | $3.9B | $1.7B | $2.1B | $2.1B | |
Operating Income | $508M | $1.1B | $1.5B | $1.5B | $1.7B | |
Net Interest Expenses | $347M | $250M | $211M | $576M | $341M | |
EBT. Incl. Unusual Items | -$19M | $475M | $1.2B | $784M | $920M | |
Earnings of Discontinued Ops. | -- | -- | $32M | -$24.8B | $875M | |
Income Tax Expense | $76M | $248M | $390M | $243M | $240M | |
Net Income to Company | -$95M | $236M | $946M | -$16.9B | -$6.6B | |
Minority Interest in Earnings | -$9M | -$6M | -$9M | -$8M | -$5M | |
Net Income to Common Excl Extra Items | -$104M | $230M | $937M | -$24.3B | $1.4B | |
Basic EPS (Cont. Ops) | -$0.18 | $0.38 | $1.55 | -$40.96 | $2.54 | |
Diluted EPS (Cont. Ops) | -$0.18 | $0.37 | $1.53 | -$40.96 | $2.52 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $4.1B | $4.7B | $5.4B | $3.6B | $4B | |
EBIT | $380M | $730M | $1.4B | $1.4B | $1.4B | |
Revenue (Reported) | $12.6B | $13.5B | $8.8B | $9.8B | $10B | |
Operating Income (Reported) | $508M | $1.1B | $1.5B | $1.5B | $1.7B | |
Operating Income (Adjusted) | $380M | $730M | $1.4B | $1.4B | $1.4B |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $9.2B | $10.2B | $9.6B | $7.3B | $7.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $6.2B | $6.4B | $6B | $4.6B | $4.7B | |
Gross Profit | $3B | $3.8B | $3.6B | $2.7B | $2.8B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.6B | $3B | $2.6B | $1.6B | $1.7B | |
Other Inc / (Exp) | $31M | -$261M | $5M | -$110M | -$225M | |
Operating Expenses | $2.6B | $3B | $2.6B | $1.6B | $1.6B | |
Operating Income | $385M | $802M | $1B | $1.1B | $1.2B | |
Net Interest Expenses | $252M | $168M | $168M | $464M | $184M | |
EBT. Incl. Unusual Items | $164M | $373M | $856M | $566M | $840M | |
Earnings of Discontinued Ops. | -- | -- | $32M | -$7.3B | $686M | |
Income Tax Expense | $95M | $246M | $233M | $136M | $223M | |
Net Income to Company | $61M | $133M | $655M | $443M | $484M | |
Minority Interest in Earnings | -$7M | -$7M | -$9M | -$5M | -$3M | |
Net Income to Common Excl Extra Items | $54M | $126M | $646M | -$6.9B | $1.2B | |
Basic EPS (Cont. Ops) | $0.08 | $0.21 | $1.07 | -$11.68 | $2.11 | |
Diluted EPS (Cont. Ops) | $0.08 | $0.21 | $1.06 | -$11.68 | $2.10 | |
Weighted Average Basic Share | $1.9B | $1.9B | $1.8B | $1.8B | $1.7B | |
Weighted Average Diluted Share | $1.9B | $1.9B | $1.8B | $1.8B | $1.7B | |
EBITDA | $3.2B | $3.5B | $3.9B | $2.4B | $2.3B | |
EBIT | $416M | $541M | $1B | $1B | $1B | |
Revenue (Reported) | $9.2B | $10.2B | $9.6B | $7.3B | $7.5B | |
Operating Income (Reported) | $385M | $802M | $1B | $1.1B | $1.2B | |
Operating Income (Adjusted) | $416M | $541M | $1B | $1B | $1B |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.2B | $2B | $2B | $456M | $440M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $3.2B | $3.3B | $3.8B | $1.8B | $1.7B | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $2.9B | -- | $530M | $439M | $463M | |
Other Current Assets | $308M | $4.3B | $2.8B | $509M | $603M | |
Total Current Assets | $8.7B | $9.9B | $10.7B | $12.8B | $13.8B | |
Property Plant And Equipment | $1.5B | $1.4B | $1.4B | $960M | $909M | |
Long-Term Investments | -- | $81M | $358M | $281M | $195M | |
Goodwill | $52.2B | $53.3B | $53.3B | $16.8B | $17B | |
Other Intangibles | $19B | $17.3B | $14.8B | $4.5B | $3.9B | |
Other Long-Term Assets | $1.7B | $959M | $977M | $26.6B | $18.1B | |
Total Assets | $83.8B | $83.8B | $82.9B | $63.3B | $55.1B | |
Accounts Payable | $1.4B | $1.6B | $1.8B | $623M | $733M | |
Accrued Expenses | $639M | $518M | $590M | $562M | $740M | |
Current Portion Of Long-Term Debt | $3B | $1.5B | $1.7B | $2.1B | $1.3B | |
Current Portion Of Capital Lease Obligations | $129M | $152M | $146M | $99M | $85M | |
Other Current Liabilities | -- | -- | -- | $7.4B | $8.9B | |
Total Current Liabilities | $10.4B | $12.4B | $14.5B | $16.2B | $18.3B | |
Long-Term Debt | $17.2B | $16B | $14.8B | $14.2B | $13B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $34.4B | $34.4B | $35.4B | $35.9B | $36B | |
Common Stock | $6M | $6M | $6M | $6M | $6M | |
Other Common Equity Adj | -$33M | $57M | $252M | -$360M | -$260M | |
Common Equity | $49.4B | $49.3B | $47.3B | $27.2B | $19.1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $16M | $187M | $185M | $188M | $6M | |
Total Equity | $49.5B | $49.5B | $47.5B | $27.4B | $19.1B | |
Total Liabilities and Equity | $83.8B | $83.8B | $82.9B | $63.3B | $55.1B | |
Cash and Short Terms | $1.2B | $2B | $2B | $456M | $440M | |
Total Debt | $20.2B | $20B | $20.4B | $20.1B | $19.1B |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.8B | $1.4B | $1.9B | $466M | $1.3B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $3.1B | $3.5B | $3.4B | $1.7B | $1.8B | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $2.8B | $3.6B | $462M | $396M | $561M | |
Other Current Assets | $823M | $489M | $2.9B | $546M | $621M | |
Total Current Assets | $9.9B | $10B | $10.6B | $12.2B | $6.1B | |
Property Plant And Equipment | $914M | $846M | $839M | $682M | $620M | |
Long-Term Investments | -- | -- | -- | -- | $4.1B | |
Goodwill | $52.6B | $52.8B | $51B | $16.8B | $17.1B | |
Other Intangibles | $17.5B | $15.2B | $12.3B | $4B | $3.6B | |
Other Long-Term Assets | $1.4B | $1.9B | $2.5B | $18.5B | $1.7B | |
Total Assets | $83.2B | $81.7B | $78.3B | $53.2B | $34.3B | |
Accounts Payable | $2.6B | $2.5B | $2.5B | $1.5B | $220M | |
Accrued Expenses | -- | -- | -- | -- | $1.1B | |
Current Portion Of Long-Term Debt | -- | $479M | $3B | $1.3B | $317M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $81M | |
Other Current Liabilities | -- | -- | -- | $7.3B | $1.3B | |
Total Current Liabilities | $12.8B | $12.6B | $13.7B | $16.1B | $5.1B | |
Long-Term Debt | $15.2B | $15.8B | $13.5B | $12.7B | $10.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $34B | $34.4B | $32.8B | $33.7B | $17.8B | |
Common Stock | $6M | $6M | $6M | $6M | $6M | |
Other Common Equity Adj | -$212M | $156M | -$392M | -$408M | -$387M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $190M | $188M | $187M | $7M | $2M | |
Total Equity | $49.2B | $47.3B | $45.5B | $19.5B | $16.6B | |
Total Liabilities and Equity | $83.2B | $81.7B | $78.3B | $53.2B | $34.3B | |
Cash and Short Terms | $1.8B | $1.4B | $1.9B | $466M | $1.3B | |
Total Debt | $20.2B | $19.8B | $18.9B | $18.7B | $10.9B |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $303M | $164M | $424M | -$16.7B | -$6.6B | |
Depreciation & Amoritzation | $2.4B | $3.7B | $4B | $3.8B | $2.7B | |
Stock-Based Compensation | $402M | $283M | $383M | $215M | $154M | |
Change in Accounts Receivable | -$161M | -$75M | -$552M | -$155M | $124M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $2.4B | $4.4B | $4.8B | $3.9B | $4.3B | |
Capital Expenditures | $828M | $1.1B | $1.3B | $1.4B | $1.1B | |
Cash Acquisitions | -$6.6B | -$469M | -$397M | $50M | -$157M | |
Cash From Investing | -$7.5B | -$914M | -$1.8B | -$373M | -$1.4B | |
Dividends Paid (Ex Special Dividend) | -$656M | -$868M | -$961M | -$1.1B | -$1.2B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $33.4B | $47.7B | $54.1B | $75.3B | $93.1B | |
Long-Term Debt Repaid | -$24.7B | -$49.1B | -$53.4B | -$74.4B | -$94.5B | |
Repurchase of Common Stock | -$453M | -$112M | -$2.1B | -$1.9B | -$522M | |
Other Financing Activities | -$151M | -$731M | -$217M | -$479M | -$387M | |
Cash From Financing | $7.6B | -$2.8B | -$2.5B | -$2.6B | -$3.5B | |
Beginning Cash (CF) | $703M | $3.2B | $4B | $4.3B | $4.8B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $2.5B | $777M | $501M | $993M | -$510M | |
Ending Cash (CF) | $3.2B | $4B | $4.3B | $4.8B | $4.4B | |
Levered Free Cash Flow | $1.6B | $3.3B | $3.6B | $2.5B | $3.2B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $103M | $291M | -$17.4B | -$7.1B | -- | |
Depreciation & Amoritzation | $954M | $1B | $926M | $1.4B | -- | |
Stock-Based Compensation | $101M | $63M | $17M | $64M | -- | |
Change in Accounts Receivable | -$153M | -$323M | -$316M | -$33M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.4B | $1.1B | $1.1B | $3B | -- | |
Capital Expenditures | $291M | $374M | $307M | $538M | -- | |
Cash Acquisitions | -- | -$767M | $38M | -$202M | -- | |
Cash From Investing | $301M | -$1.2B | -$205M | -$755M | -- | |
Dividends Paid (Ex Special Dividend) | -$218M | -$237M | -$280M | -$305M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $10.6B | $13.5B | $25.3B | $28.7B | -- | |
Long-Term Debt Repaid | -$11.4B | -$12.8B | -$25.1B | -$28.7B | -- | |
Repurchase of Common Stock | -$10M | -$1M | -$548M | -$522M | -- | |
Other Financing Activities | -$509M | -$5M | -$127M | -$204M | -- | |
Cash From Financing | -$1.6B | $499M | -$683M | -$1B | -- | |
Beginning Cash (CF) | $3.8B | $4B | $4.2B | $4.1B | -- | |
Foreign Exchange Rate Adjustment | $34M | -$191M | $319M | $140M | -- | |
Additions / Reductions | $161M | $438M | $253M | $193M | -- | |
Ending Cash (CF) | $4B | $4.3B | $4.8B | $4.4B | -- | |
Levered Free Cash Flow | $1.1B | $739M | $834M | $2.5B | -- |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$95M | $236M | $946M | -$16.9B | -$6.6B | |
Depreciation & Amoritzation | $3.7B | $3.9B | $4B | $2.2B | $2.6B | |
Stock-Based Compensation | $446M | $421M | $261M | $107M | $206M | |
Change in Accounts Receivable | -$81M | -$382M | -$162M | -$159M | -$144M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $3.7B | $5.1B | $3.9B | $2.4B | $4.4B | |
Capital Expenditures | $1.1B | $1.2B | $1.5B | $891M | $1.2B | |
Cash Acquisitions | -$472M | $370M | -$755M | $83M | $9.4B | |
Cash From Investing | -$1.5B | -$296M | -$1.3B | -$802M | $8.1B | |
Dividends Paid (Ex Special Dividend) | -$865M | -$942M | -$1.1B | -$1.2B | -$913M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $45.1B | $51.1B | $63.5B | $89.8B | $44.5B | |
Long-Term Debt Repaid | -$46.3B | -$52.1B | -$62.1B | -$90.9B | -$52.9B | |
Repurchase of Common Stock | -$133M | -$2.1B | -$1.4B | -- | -- | |
Other Financing Activities | -$263M | -$721M | -$357M | -$310M | -$165M | |
Cash From Financing | -$2.2B | -$4.6B | -$1.4B | -$3.2B | -$13B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$59M | $224M | $1.2B | -$450M | -$1.7B | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $2.6B | $3.9B | $2.5B | $1.6B | $3.3B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $164M | $424M | -$16.7B | -$6.6B | $484M | |
Depreciation & Amoritzation | $3.7B | $4B | $3.8B | $2.7B | $1.3B | |
Stock-Based Compensation | $283M | $383M | $215M | $154M | $142M | |
Change in Accounts Receivable | -$75M | -$552M | -$155M | $124M | -$111M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $4.4B | $4.8B | $3.9B | $4.3B | $1.4B | |
Capital Expenditures | $1.1B | $1.3B | $1.4B | $1.1B | $629M | |
Cash Acquisitions | -$469M | -$397M | $50M | -$157M | $9.6B | |
Cash From Investing | -$914M | -$1.8B | -$373M | -$1.4B | $8.8B | |
Dividends Paid (Ex Special Dividend) | -$868M | -$961M | -$1.1B | -$1.2B | -$608M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $47.7B | $54.1B | $75.3B | $93.1B | $15.8B | |
Long-Term Debt Repaid | -$49.1B | -$53.4B | -$74.4B | -$94.5B | -$24.2B | |
Repurchase of Common Stock | -$112M | -$2.1B | -$1.9B | -$522M | -- | |
Other Financing Activities | -$731M | -$217M | -$479M | -$387M | $39M | |
Cash From Financing | -$2.8B | -$2.5B | -$2.6B | -$3.5B | -$12B | |
Beginning Cash (CF) | $13.9B | $14.5B | $16.3B | $17.6B | $11.6B | |
Foreign Exchange Rate Adjustment | $42M | -$248M | -$463M | $111M | -$10M | |
Additions / Reductions | $777M | $501M | $993M | -$510M | -$1.9B | |
Ending Cash (CF) | $14.8B | $14.7B | $16.8B | $17.2B | $9.7B | |
Levered Free Cash Flow | $3.3B | $3.6B | $2.5B | $3.2B | $764M |
Signup to receive the latest stock alerts
2024 was another banner year for the US stock market,…
Carlos Slim made a splash in a surprising sector last…
There is a lot of humdrum in the market about…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.4T
P/E Ratio: 116x
Market Cap: $3.1T
P/E Ratio: 35x
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Banco Macro SA [BMA] is up 0.88% over the past day.
Agrify [AGFY] is down 5.86% over the past day.